• EMD638683: From SGK1 Signaling to Vascular Translation

  2026-08-24

  EMD638683 offers translational researchers a selective SGK-family chemical probe for connecting endothelial SGK1 signaling with sodium-channel regulation, actin remodeling, vascular stiffness, and tumor biology. This article interprets recent mechanistic evidence, outlines practical validation workflows, and explains how to position the compound responsibly across hypertension and cancer research.

• MRT68921: ULK1 Kinase Inhibitor Workflows

  2026-08-24

  MRT68921 enables direct, time-resolved interrogation of ULK1/2 activity instead of relying on energy-stress assumptions about AMPK. This workflow-oriented guide covers stock preparation, ATG13 phosphorylation blockade, LC3 flux measurement, controls, and troubleshooting for rigorous cell-based autophagy studies.

• Humanized Mice Clarify HD56 Prodrug Metabolism

  2026-08-22

  This 2025 study shows that the ester prodrug HD56 has markedly different disposition across species and that humanized-liver mice provide the strongest in vivo–in vitro correlation for conversion to HD561. Its findings offer a practical framework for evaluating carboxylesterase-dependent prodrugs before clinical development.

• Ridaforolimus for mTOR and Senescence Research

  2026-08-21

  Ridaforolimus, also called Deforolimus or MK-8669, provides a potent mTOR pathway perturbation for cancer-cell growth, signaling, and VEGF studies. This guide translates its published activity into reproducible workflows and shows how to pair pathway readouts with machine-learning-informed senescence assays without overcalling a senolytic effect.

• GW 4869: Reframing Exosomal Injury in Lupus Nephritis

  2026-08-20

  A translational perspective on how GW 4869 links neutral sphingomyelinase activity, ceramide signaling, and podocyte–endothelial communication in lupus nephritis.

• Medroxyprogesterone acetate: Decidualization Workflows

  2026-08-20

  Medroxyprogesterone acetate (MPA) supports controlled studies of steroid signaling, endometrial decidualization, renal epithelial gene regulation, and neuroendocrine outcomes. This guide connects practical dosing and solubility decisions with ACSL4–fatty acid β-oxidation biology, helping researchers distinguish pathway activation from nonspecific lipid accumulation.

• tFUS Regulates the Nespas/miR-383-3p/SHP2 Axis

  2026-08-19

  This study identifies a molecular mechanism by which low-intensity transcranial focused ultrasound (tFUS) reduces post-stroke neuroinflammation. Its central finding is that tFUS protects against NLRP3 inflammasome activation through the microglial Nespas/miR-383-3p/SHP2 axis, providing a mechanistic basis for noninvasive neuromodulation after ischemic stroke.

• HotStart™ 2X Green qPCR Master Mix Guide

  2026-08-19

  HotStart™ 2X Green qPCR Master Mix supports SYBR Green real-time PCR workflows where nonspecific products, primer-dimers, or variable reaction setup can compromise quantification. It is suited to DNA and cDNA assays, including gene expression analysis and RNA-seq validation, but it should not be treated as sequence-specific detection or as a substitute for melt-curve and control-based assay validation.

• Neurotensin: Analytical Design for NTR1 Studies

  2026-08-18

  Neurotensin is a versatile Neurotensin receptor 1 activator for connecting GPCR trafficking with miR-133α modulation. This guide adds an analytical-quality framework, showing how spectral interference controls can improve interpretation of gastrointestinal cell assays.

• KG-501: From CREB–KIX Mechanism to Translation

  2026-08-18

  KG-501 is a mechanism-focused probe for testing CREB–CBP KIX disruption in transcriptional, cancer, and macrophage models. This article places the compound within a translational framework, using colorectal cancer immunology findings to define appropriate evidence standards, assay strategies, and limitations.

• B7H3×CD3 BiTE mRNA-LNPs in Cancer Therapy

  2026-08-17

  Huang and colleagues developed an ionizable lipid nanoparticle system for delivering mRNA encoding a B7H3×CD3 bispecific T-cell engager. Their findings show that a single intravenous administration produced sustained BiTE expression and durable antitumor activity in models of hematologic malignancy and melanoma, addressing major limitations of recombinant BiTE therapy.

• PBS Liposomes for Macrophage Control Studies

  2026-08-17

  PBS Liposomes provide a phagocytosis-matched negative control that separates liposome handling effects from clodronate-mediated macrophage depletion. This workflow shows how to pair them with depletion, uptake, cytokine, and TRPM3-related assays for more defensible causal conclusions.

• Beyond Viability: Measuring Drug Responses in Cancer

  2026-08-16

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of anticancer drug response. This framework supports more interpretable in vitro screening by aligning endpoint selection and sampling time with the biological process being measured.

• Caffeine N2379: Reproducible Cell Assays

  2026-08-15

  This scenario-based guide explains how Caffeine (SKU N2379) can support better-controlled viability, proliferation, and cytotoxicity experiments. It covers assay interpretation, solvent compatibility, concentration planning, combination studies, and evidence-based vendor selection.

• CBD, FAAH, and Orofacial Inflammatory Pain

  2026-08-14

  A 2026 Brain Research Bulletin study shows that cannabidiol reduces both nociceptive and pain-related affective abnormalities in mouse inflammatory pain models through coordinated peripheral and central endocannabinoid mechanisms. Its design links FAAH, anandamide, inflammatory mediators, trigeminal activity, and amygdala serotonin dynamics, providing a framework for interpreting multidimensional analgesic responses.

8591 records 1/573 page Next 12345 下5页 Last page